Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-08-30

Clinical Trial Update: The Efficacy of Qianglidingxuan Tablets in the Treatment of Hypertension [Phase 4]

View source ↗

Summary

Phase 4 trial updating the efficacy of Qianglidingxuan tablets for hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Qianglidingxuan tablets

Snippet

Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences | Conditions: Hypertension, Medicine, Chinese Traditional | Phase 4 | Status: COMPLETED